ATE205401T1 - Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8 - Google Patents
Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8Info
- Publication number
- ATE205401T1 ATE205401T1 AT98930578T AT98930578T ATE205401T1 AT E205401 T1 ATE205401 T1 AT E205401T1 AT 98930578 T AT98930578 T AT 98930578T AT 98930578 T AT98930578 T AT 98930578T AT E205401 T1 ATE205401 T1 AT E205401T1
- Authority
- AT
- Austria
- Prior art keywords
- psoriasis
- neutralizing antibodies
- local treatment
- biological activity
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97112184A CN1068524C (zh) | 1997-06-23 | 1997-06-23 | 一种治疗顽症牛皮癣的药物 |
PCT/CA1998/000604 WO1998058671A1 (en) | 1997-06-23 | 1998-06-23 | Topical treatment of psoriasis using neutralizing antibodies to il-8 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE205401T1 true ATE205401T1 (de) | 2001-09-15 |
Family
ID=5172124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98930578T ATE205401T1 (de) | 1997-06-23 | 1998-06-23 | Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030077283A1 (de) |
EP (1) | EP0991423B1 (de) |
CN (1) | CN1068524C (de) |
AT (1) | ATE205401T1 (de) |
AU (1) | AU727937B2 (de) |
CA (1) | CA2291144C (de) |
DE (1) | DE69801660T2 (de) |
ES (1) | ES2164434T3 (de) |
WO (1) | WO1998058671A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002252444A1 (en) * | 2001-03-23 | 2002-10-08 | Board Of Regents, The University Of Texas System | Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors |
FR2830449B1 (fr) * | 2001-10-05 | 2004-04-23 | Fabre Pierre Dermo Cosmetique | Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant |
ES2373947T3 (es) | 2002-12-16 | 2012-02-10 | Genmab A/S | Anticuerpos monoclonales humanos contra interleucina 8 (il-8). |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
JP5334319B2 (ja) | 2007-09-26 | 2013-11-06 | 中外製薬株式会社 | Cdrのアミノ酸置換により抗体の等電点を改変する方法 |
AU2010222818B2 (en) * | 2009-03-09 | 2015-05-14 | Bioatla, Llc | Mirac proteins |
EP2647706B1 (de) | 2010-11-30 | 2023-05-17 | Chugai Seiyaku Kabushiki Kaisha | Antigenbindende moleküle zur wiederholten bindung an mehrere antigenmoleküle |
US11236168B2 (en) | 2012-08-24 | 2022-02-01 | Chugai Seiyaku Kabushiki Kaisha | Mouse FcγammaRII-specific Fc antibody |
WO2014163101A1 (ja) | 2013-04-02 | 2014-10-09 | 中外製薬株式会社 | Fc領域改変体 |
CN105521489A (zh) * | 2014-09-28 | 2016-04-27 | 徐州逸仕生物技术有限公司 | 抗人TNF-αIgY抗体及其治疗皮肤疾病的应用 |
KR20180054923A (ko) | 2014-12-19 | 2018-05-24 | 추가이 세이야쿠 가부시키가이샤 | 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법 |
MX2017008978A (es) | 2015-02-05 | 2017-10-25 | Chugai Pharmaceutical Co Ltd | Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, antiocuerpor de union a interleucina 8 (il-8) y usos de los mismos. |
RO130965A8 (ro) * | 2015-10-16 | 2017-06-30 | Romvac Company S.A. | Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului |
US11359009B2 (en) | 2015-12-25 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin antibodies and methods of use |
US11053308B2 (en) | 2016-08-05 | 2021-07-06 | Chugai Seiyaku Kabushiki Kaisha | Method for treating IL-8-related diseases |
SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
MX2019005833A (es) | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
CN111770936A (zh) | 2018-01-12 | 2020-10-13 | 百时美施贵宝公司 | 抗il-8抗体和抗pd-1抗体联合治疗用于治疗癌症 |
CN112119090B (zh) | 2018-03-15 | 2023-01-13 | 中外制药株式会社 | 对寨卡病毒具有交叉反应性的抗登革热病毒抗体及使用方法 |
CN109481674A (zh) * | 2018-11-14 | 2019-03-19 | 大连亚维药业有限公司 | 一种生物无菌乳膏药物的生产方法 |
WO2023192478A1 (en) | 2022-04-01 | 2023-10-05 | Bristol-Myers Squibb Company | Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364933A (en) * | 1979-12-04 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to a human thymocyte antigen and methods of preparing same |
GB9009548D0 (en) * | 1990-04-27 | 1990-06-20 | Celltech Ltd | Chimeric antibody and method |
US5440021A (en) * | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
EP0563487A1 (de) * | 1992-03-31 | 1993-10-06 | Laboratoire Europeen De Biotechnologie S.A. | Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon |
US5707621A (en) * | 1994-08-31 | 1998-01-13 | Chugai Pharmaceutical Co., Ltd. | Supression of nephritis-induced protein excretion by anti-IL-8 |
JPH08277299A (ja) * | 1995-04-06 | 1996-10-22 | Fujirebio Inc | 抗il−8抗体、抗il−8モノクローナル抗体を産生するハイブリドーマ及び該抗体を用いたil−8の測定方法 |
BR9713498A (pt) * | 1996-11-08 | 2000-02-29 | Idec Pharma Corp | Identificação de interações de ligação singulares entre alguns anticorpos e os antìgenos co-estimulatórios b7.1 e b7.2 humanos |
-
1997
- 1997-06-23 CN CN97112184A patent/CN1068524C/zh not_active Expired - Fee Related
-
1998
- 1998-06-23 WO PCT/CA1998/000604 patent/WO1998058671A1/en active IP Right Grant
- 1998-06-23 DE DE69801660T patent/DE69801660T2/de not_active Expired - Lifetime
- 1998-06-23 CA CA002291144A patent/CA2291144C/en not_active Expired - Fee Related
- 1998-06-23 ES ES98930578T patent/ES2164434T3/es not_active Expired - Lifetime
- 1998-06-23 AU AU80962/98A patent/AU727937B2/en not_active Ceased
- 1998-06-23 AT AT98930578T patent/ATE205401T1/de not_active IP Right Cessation
- 1998-06-23 EP EP98930578A patent/EP0991423B1/de not_active Expired - Lifetime
-
2001
- 2001-09-21 US US09/956,968 patent/US20030077283A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1068524C (zh) | 2001-07-18 |
CN1203105A (zh) | 1998-12-30 |
AU8096298A (en) | 1999-01-04 |
EP0991423B1 (de) | 2001-09-12 |
AU727937B2 (en) | 2001-01-04 |
DE69801660D1 (de) | 2001-10-18 |
ES2164434T3 (es) | 2002-02-16 |
US20030077283A1 (en) | 2003-04-24 |
EP0991423A1 (de) | 2000-04-12 |
WO1998058671A1 (en) | 1998-12-30 |
CA2291144C (en) | 2001-07-03 |
DE69801660T2 (de) | 2002-06-06 |
CA2291144A1 (en) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE205401T1 (de) | Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8 | |
EA200100721A1 (ru) | Производное габапентина для предупреждения и лечения висцеральной боли | |
ATE354655T1 (de) | Humane antikörper gegen ctla-4 und deren verwendungen | |
DE69940975D1 (de) | Verwendung von glp-1 oder analoge zur behandlung von schlaganfall | |
DE69738615D1 (de) | Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt | |
PT1017692E (pt) | 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep) | |
ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
BR9305783A (pt) | Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água | |
AR004170A1 (es) | Peptidos ciclicos semisinteticos, utiles como inhibidores de hongos y parasitos; procedimiento para prepararlos, formulaciones que los incluyeny metodo para tratar infecciones fungicas con aplicacion de dichas formulaciones | |
PT1173201E (pt) | Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina | |
NO995843L (no) | Farmasoeytisk preparat omfattende vWF-propeptid | |
ATE484294T1 (de) | Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen | |
MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
PT1237562E (pt) | Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas | |
DE69132575T2 (de) | Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe | |
ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
AP9801416A0 (en) | Method Of treating a plant disease. | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
ATE171070T1 (de) | Neue verwendung von equisetum | |
DK0820308T3 (da) | Konjugat til behandling af inflammatoriske sygdomme | |
DE69831336D1 (de) | Tazaroten und uvb-phototherapie zur behandlung von psoriasis | |
DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
FR2706128B1 (fr) | Procédé de préparation de déjections animales, déjections animales désodorisées et leur utilisation . |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |